These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 20800022
1. Preliminary efficacy of CyberKnife radiosurgery for locally advanced pancreatic cancer. Shen ZT, Wu XH, Li B, Wang L, Zhu XX. Chin J Cancer; 2010 Sep; 29(9):802-9. PubMed ID: 20800022 [Abstract] [Full Text] [Related]
2. Stereotactic body radiotherapy using CyberKnife for locally advanced unresectable and metastatic pancreatic cancer. Su TS, Liang P, Lu HZ, Liang JN, Liu JM, Zhou Y, Gao YC, Tang MY. World J Gastroenterol; 2015 Jul 14; 21(26):8156-62. PubMed ID: 26185389 [Abstract] [Full Text] [Related]
3. Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 patients. Didolkar MS, Coleman CW, Brenner MJ, Chu KU, Olexa N, Stanwyck E, Yu A, Neerchal N, Rabinowitz S. J Gastrointest Surg; 2010 Oct 14; 14(10):1547-59. PubMed ID: 20839073 [Abstract] [Full Text] [Related]
4. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity. Goldsmith C, Plowman PN, Green MM, Dale RG, Price PM. Radiat Oncol; 2018 Oct 19; 13(1):204. PubMed ID: 30340643 [Abstract] [Full Text] [Related]
5. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Brown WT, Wu X, Fayad F, Fowler JF, Amendola BE, García S, Han H, de la Zerda A, Bossart E, Huang Z, Schwade JG. Clin Lung Cancer; 2007 Sep 19; 8(8):488-92. PubMed ID: 17922973 [Abstract] [Full Text] [Related]
6. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, Kang JH, Yoo EJ, Yoon SC, Jang HS, Chung SM, Kim YS. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1348-55. PubMed ID: 19117695 [Abstract] [Full Text] [Related]
7. [Preliminary effect of Cyberknife radiosurgery in the treatment of 31 patients with advanced non-small cell lung cancer]. Lv Y, Wang Z, Zhu X, Shen Z, Yuan D, Miao X, Shi Y, Song Y. Zhongguo Fei Ai Za Zhi; 2011 Apr 01; 14(4):329-34. PubMed ID: 21496431 [Abstract] [Full Text] [Related]
9. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort. Balermpas P, Stera S, Müller von der Grün J, Loutfi-Krauss B, Forster MT, Wagner M, Keller C, Rödel C, Seifert V, Blanck O, Wolff R. PLoS One; 2018 Jul 01; 13(6):e0198692. PubMed ID: 29874299 [Abstract] [Full Text] [Related]
10. CyberKnife radiotherapy for orbital metastases: A single-center experience on 24 lesions. Riva G, Augugliaro M, Piperno G, Ferrari A, Rondi E, Vigorito S, Ciardo D, Orecchia R, Jereczek-Fossa BA. Eur J Ophthalmol; 2019 Jan 01; 29(1):61-68. PubMed ID: 29587486 [Abstract] [Full Text] [Related]
11. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume. Yamazaki H, Ogita M, Himei K, Nakamura S, Yoshida K, Kotsuma T, Yamada Y, Fujiwara M, Baek S, Yoshioka Y. Anticancer Res; 2014 Oct 01; 34(10):5755-9. PubMed ID: 25275085 [Abstract] [Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Kong L, Zhang YW, Hu CS, Guo Y. Chin J Cancer; 2010 May 01; 29(5):551-5. PubMed ID: 20426907 [Abstract] [Full Text] [Related]
17. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery. Yamada Y, Katsoulakis E, Laufer I, Lovelock M, Barzilai O, McLaughlin LA, Zhang Z, Schmitt AM, Higginson DS, Lis E, Zelefsky MJ, Mechalakos J, Bilsky MH. Neurosurg Focus; 2017 Jan 01; 42(1):E6. PubMed ID: 28041329 [Abstract] [Full Text] [Related]
18. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Jereczek-Fossa BA, Beltramo G, Fariselli L, Fodor C, Santoro L, Vavassori A, Zerini D, Gherardi F, Ascione C, Bossi-Zanetti I, Mauro R, Bregantin A, Bianchi LC, De Cobelli O, Orecchia R. Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):889-97. PubMed ID: 21277113 [Abstract] [Full Text] [Related]